Anne-Marie Wills MD MPH is a Neurologist specializing in neurodegenerative disease, such as Parkinson's Disease, Progressive Supranuclear Palsy (PSP), and ALS. She received her BA from Princeton University, her MD from Columbia College Physicians & Surgeons, and her MPH from Harvard School of Public Health. She completed her specialty training in the Mass General Brigham Neurology residency program, a combined program between Massachusetts General Hospital and Brigham and Women's Hospital. She has been on staff at Mass General since 2006.

Dr. Wills' research focuses on genetic and environmental risk factors for neurodegenerative diseases, particularly PSP and Parkinson's disease. She is the director of the CurePSP Center of Care at MGH which provides multidisciplinary care for people with Progressive Supranuclear Palsy. She is a member of the Movement Disorders Society, the Parkinson's Study Group (PSG), the American Academy of Neurology, serves on the Steering Committees of the the Progressive Supranuclear Palsy Study Group (PSP) of the International Parkinson and Movement Disorder Society, the Parkinson's Foundation's PDGeneration study, and is co-founder of the Atypical Parkinsonian Disorders working group of the PSG.  She is the PI of multiple clinical trials in Parkinson's disease and PSP including PI of the CurePSP Genetics Program and Co-PI of the multicenter Progressive Supranuclear Palsy Clinical Trial Platform (PTP).

High-calorie feeding may slow progression of ALS